Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)

Sponsor
AstraZeneca
Study ID
NCT07279948
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 80 Years
Healthy Volunteers
Not accepted

Study Details

A prospective, longitudinal, single-arm interventional study of lung cancer screening.

Key Dates

First listed
Dec 12, 2025
Start date
Jun 30, 2026
Status verified
Jun 2026
Primary completion
Jan 31, 2027
Completion
Jan 31, 2027

Study Design

Enrollment
477 participants (estimated)

Primary Outcome Measure

• Proportion of negative cases on screening according to the Lung-RADS classification. [ Time Frame: Last 10 years ]

Central Contacts

Find similar trials

Nationwide
Lung cancer trialsOncology trialsLung oncology trialsLung disease trials

Related Studies